Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance

被引：16
作者：
Zhang, Haozhe [1 ]
Zhou, Yi [1 ]
Xing, Zengzhen [1 ]
Sah, Rajiv Kumar [1 ]
Hu, Junqi [1 ]
Hu, Hailiang [1 ,2 ]
机构：
[1] So Univ Sci & Technol, Sch Med, Dept Biochem, Shenzhen 518055, Peoples R China
[2] Southern Univ Sci & Technol, Key Univ Lab Metab & Hlth Guangdong, Shenzhen 518055, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2022年 / 23卷 / 21期
基金：
中国国家自然科学基金;
关键词：
androgen metabolism; androgen receptor; anti-androgen therapy; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; UDP-GLUCURONOSYLTRANSFERASES; INDEPENDENT GROWTH; CYP17A1; INHIBITION; BACKDOOR PATHWAY; RECEPTOR; CASTRATION; TESTOSTERONE; ABIRATERONE; EXPRESSION;
D O I：
10.3390/ijms232113521
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
All aspects of prostate cancer evolution are closely related to androgen levels and the status of the androgen receptor (AR). Almost all treatments target androgen metabolism pathways and AR, from castration-sensitive prostate cancer (CSPC) to castration-resistant prostate cancer (CRPC). Alterations in androgen metabolism and its response are one of the main reasons for prostate cancer drug resistance. In this review, we will introduce androgen metabolism, including how the androgen was synthesized, consumed, and responded to in healthy people and prostate cancer patients, and discuss how these alterations in androgen metabolism contribute to the resistance to anti-androgen therapy.
引用
收藏
页数：15
相关论文
共 117 条
  • [91] STRUCTURE AND EXPRESSION OF A NEW COMPLEMENTARY-DNA ENCODING THE ALMOST EXCLUSIVE 3-BETA-HYDROXYSTEROID DEHYDROGENASE DELTA-5-DELTA-4-ISOMERASE IN HUMAN ADRENALS AND GONADS
    RHEAUME, E
    LACHANCE, Y
    ZHAO, HF
    BRETON, N
    DUMONT, M
    DELAUNOIT, Y
    TRUDEL, C
    LUUTHE, V
    SIMARD, J
    LABRIE, F
    [J]. MOLECULAR ENDOCRINOLOGY, 1991, 5 (08) : 1147 - 1157
  • [92] The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
    Rowland, Andrew
    Miners, John O.
    Mackenzie, Peter I.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (06) : 1121 - 1132
  • [93] FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
    Sahu, Biswajyoti
    Laakso, Marko
    Pihlajamaa, Paivi
    Ovaska, Kristian
    Sinielnikov, Ievgenii
    Hautaniemi, Sampsa
    Janne, Olli A.
    [J]. CANCER RESEARCH, 2013, 73 (05) : 1570 - 1580
  • [94] Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
    Stanbrough, M
    Bubley, GJ
    Ross, K
    Golub, TR
    Rubin, MA
    Penning, TM
    Febbo, PG
    Balk, SP
    [J]. CANCER RESEARCH, 2006, 66 (05) : 2815 - 2825
  • [95] Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer
    Steketee, K
    Timmerman, L
    Ziel-van der Made, ACJ
    Doesburg, P
    Brinkmann, AO
    Trapman, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (03) : 309 - 317
  • [96] Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease
    Su, Wen
    Wang, Yang
    Jia, Xiao
    Wu, Wenhan
    Li, Linghai
    Tian, Xiaodong
    Li, Sha
    Wang, Chunjiong
    Xu, Huamin
    Cao, Jiaqi
    Han, Qifei
    Xu, Shimeng
    Chen, Yong
    Zhong, Yanfeng
    Zhang, Xiaoyan
    Liu, Pingsheng
    Gustafsson, Jan-Ake
    Guan, Youfei
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (31) : 11437 - 11442
  • [97] Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Laversanne, Mathieu
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    Bray, Freddie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) : 209 - 249
  • [98] OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
    Supiot, Stephane
    Vaugier, Loig
    Pasquier, David
    Buthaud, Xavier
    Magne, Nicolas
    Peiffert, Didier
    Sargos, Paul
    Crehange, Gilles
    Pommier, Pascal
    Loos, Genevieve
    Hasbini, Ali
    Latorzeff, Igor
    Silva, Marlon
    Denis, Fabrice
    Lagrange, Jean-Leon
    Morvan, Cyrille
    Campion, Loic
    Blanc-Lapierre, Audrey
    [J]. EUROPEAN UROLOGY, 2021, 80 (04) : 405 - 414
  • [99] Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum
    Tamae, Daniel
    Byrns, Michael
    Marck, Brett
    Mostaghel, Elahe
    Nelson, Peter S.
    Lange, Paul
    Lin, Daniel
    Taplin, Mary-Ellen
    Balk, Steven
    Ellis, William
    True, Larry
    Vessella, Robert
    Montgomery, Bruce
    Blair, Ian A.
    Penning, Trevor M.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 138 : 281 - 289
  • [100] Steroid 5α-reductase isozymes I and II in recurrent prostate cancer
    Titus, MA
    Gregory, CW
    Ford, OH
    Schell, MJ
    Maygarden, SJ
    Mohler, JL
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (12) : 4365 - 4371
3456789101112